LAB · Standard Biotools Inc.
$0.71
-0.04 (-4.99%)
At close · Aug 14
Market Cap
$279.67M
Shares
392.58M
Standard Biotools Inc. Earnings Call Transcripts
Every quarterly earnings call for Standard Biotools Inc. (LAB) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼28.5%
$28.50M
−$13.84M
'21 Q3
21-11-08
▼14.2%
$38.27M
−$9.43M
'21 Q4
22-02-18
▼19.2%
$26.50M
−$76.29M
'22 Q1
22-05-05
▼39.5%
$18.78M
−$63.54M
'22 Q2
22-08-08
▼10%
$25.65M
−$29.43M
'22 Q3
22-11-08
▼29.4%
$27.02M
−$20.84M
'22 Q4
23-01-09
▼5.2%
$25.12M
−$16.84M
'23 Q1
23-05-09
▲47.3%
$27.67M
−$17.04M
'23 Q2
23-08-08
▼1.1%
$25.37M
−$21.00M
'23 Q3
23-11-07
▲4.3%
$28.19M
−$19.78M
'23 Q4
24-01-08
▲81.3%
$45.54M
−$32.16M
'24 Q1
24-03-31
▼18.7%
$22.49M
−$45.72M
'24 Q2
24-07-31
▼12.9%
$22.09M
−$26.94M
'24 Q3
24-10-30
▼96.8%
$890,000
−$34.07M
'24 Q4
25-01-13
▼55.6%
$20.22M
−$26.03M
'25 Q1
25-05-06
LATEST
▼3.2%
$21.76M
−$33.46M
'25 Q2
25-08-11
Earnings call
FY25 · Q2
2025-08-11
Standard Biotools Inc. Q2 FY2025 Earnings Call
Revenue
$21.76M
▼ 3.2% YoY Diluted EPS
$-0.09
Gross margin
48.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Standard Biotools Inc. Q1 FY2025 Earnings Call
Revenue
$20.22M
▼ 55.6% YoY Diluted EPS
$-0.07
Gross margin
54.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
Standard Biotools Inc. Q4 FY2024 Earnings Call
Positive tone
SomaLogic Integration & SomaScan
Macro/Policy Backdrop Risk
China Market & Geopolitics
Revenue
$890,000*
▼ 96.8% YoY Gross margin
-202.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Standard Biotools Inc. Q3 FY2024 Earnings Call
Positive tone
Consumables growth
Geographic performance including China
Revenue guidance reiteration and 2025 outlook
Revenue
$22.09M
▼ 12.9% YoY Diluted EPS
$-0.07
Gross margin
54.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
Standard Biotools Inc. Q2 FY2024 Earnings Call
Positive tone
Illumina partnership and NovaSeq platform
Leadership transition (CFO departure)
SomaScan services and customer concentration
Revenue
$22.49M
▼ 18.7% YoY Diluted EPS
$-0.12
Gross margin
46.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Standard Biotools Inc. Q1 FY2024 Earnings Call
Positive tone
Illumina NGS partnership
SomaScan assay and proteomics growth
SomaLogic integration and synergies
Revenue
$45.54M
▲ 81.3% YoY Diluted EPS
$-0.27
Gross margin
53.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
Standard Biotools Inc. Q4 FY2023 Earnings Call
Confident tone
SomaLogic merger and integration
Product portfolio and technology platforms
Revenue growth and 2024 guidance
Revenue
$28.19M*
▲ 4.3% YoY Gross margin
47.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Standard Biotools Inc. Q3 FY2023 Earnings Call
Revenue
$25.37M
▼ 1.1% YoY Diluted EPS
$-0.27
Gross margin
44.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Standard Biotools Inc. Q2 FY2023 Earnings Call
Revenue
$27.67M
▲ 47.3% YoY Diluted EPS
$-0.22
Gross margin
49.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Standard Biotools Inc. Q1 FY2023 Earnings Call
Revenue
$25.12M
▼ 5.2% YoY Diluted EPS
$-0.21
Gross margin
48.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Standard Biotools Inc. Q4 FY2022 Earnings Call
Revenue
$27.02M*
▼ 29.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Standard Biotools Inc. Q3 FY2022 Earnings Call
Revenue
$25.65M
▼ 10% YoY Diluted EPS
$-0.37
Gross margin
36.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Standard Biotools Inc. Q2 FY2022 Earnings Call
Revenue
$18.78M
▼ 39.5% YoY Diluted EPS
$-0.82
Gross margin
23.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Standard Biotools Inc. Q1 FY2022 Earnings Call
Revenue
$26.50M
▼ 19.2% YoY Diluted EPS
$-0.99
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-18
Standard Biotools Inc. Q4 FY2021 Earnings Call
Revenue
$38.27M*
▼ 14.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Standard Biotools Inc. Q3 FY2021 Earnings Call
Revenue
$28.50M
▼ 28.5% YoY Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Standard Biotools Inc. Q2 FY2021 Earnings Call
Revenue
$31.02M
▲ 19% YoY Diluted EPS
$-0.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Standard Biotools Inc. Q1 FY2021 Earnings Call
Revenue
$32.79M
▲ 18.7% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-10
Standard Biotools Inc. Q4 FY2020 Earnings Call
Revenue
$44.61M
▲ 37.5% YoY Gross margin
49.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Standard Biotools Inc. Q3 FY2020 Earnings Call
Revenue
$39.86M
▲ 50.4% YoY Diluted EPS
$-0.08
Gross margin
52.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Standard Biotools Inc. Q2 FY2020 Earnings Call
Revenue
$26.06M
▼ 7.6% YoY Diluted EPS
$-0.18
Gross margin
45.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Standard Biotools Inc. Q1 FY2020 Earnings Call
Revenue
$27.62M
▼ 8.3% YoY Gross margin
47.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-14
Standard Biotools Inc. Q4 FY2019 Earnings Call
Revenue
$32.44M
▲ 0.4% YoY Gross margin
54.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–23 of 23 earnings calls
Key facts
CIK
1162194
CUSIP
34385P108
13F (30d)
141 filings
137 filers
Visit website
Investor relations